GSK CEO: Our top priority is to invest in growth in our core pharma business 5 Hours Ago Emma Walmsley, GlaxoSmithKlein CEO, speaks to CNBC's Meg Tirrell at the J.P. Morgan Health Care Conference about reshaping the company and her outlook for 2018.